95 related articles for article (PubMed ID: 15849866)
1. [Influence of L-DOPA on rat brain depending on individual behavioral features].
Sergutina AV; Gershteĭn LM
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):56-9. PubMed ID: 15849866
[TBL] [Abstract][Full Text] [Related]
2. [The effect of withdrawal from L-DOPA compounds on pathochemical changes of motor structures of the brain caused by them].
Gershteĭn LM; Sergutina AV; Kukuev LA
Vopr Med Khim; 1994; 40(5):4-8. PubMed ID: 7839669
[TBL] [Abstract][Full Text] [Related]
3. [Pathochemical changes in the motor structures of the brain under the influence of the administration of L-DOPA preparations and their withdrawal (experimental research)].
Kukuev LA; Sergutina AV; Gershteĭn LM
Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(5):28-32. PubMed ID: 7900446
[TBL] [Abstract][Full Text] [Related]
4. [Comparative cytochemical study of the central nervous system in Wistar and August rats in dopamine system hyperfunction].
Sergutina AV
Morfologiia; 1998; 113(1):51-3. PubMed ID: 9606663
[TBL] [Abstract][Full Text] [Related]
5. [The morphochemical characteristics of the reaction of the motor structures of the brain to hyper- and hypofunction of the dopaminergic system].
Gershteĭn LM; Dovedova EL; Dobrynina MT; Sergutina AV; Rakhmanova VI
Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(6):49-53. PubMed ID: 9072895
[TBL] [Abstract][Full Text] [Related]
6. [Effect of L-dihydroxyphenylalanine on rat behavior and on catecholamine metabolism of the brain in rats with different degrees of emotional-behavioral reactivity].
Bondarenko NA; Miroshnichenko II; Kudrin VS; Bondarenko NA
Biull Eksp Biol Med; 1988 Aug; 106(8):168-70. PubMed ID: 3416051
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
Eltayb A; Wadenberg ML; Svensson TH
Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical characteristics of the effects of delta sleep-inducing peptide in Wistar rats with hyperactivity of the dopaminergic system.
Sergutina AV; Gershtein LM
Bull Exp Biol Med; 2000 Nov; 130(11):1074-6. PubMed ID: 11182819
[TBL] [Abstract][Full Text] [Related]
9. Brain acetylcholinesterase activity in Wistar and August rats with low and high motor activity (a cytochemical study).
Sergutina AV; Rakhmanova VI
Bull Exp Biol Med; 2014 Aug; 157(4):450-3. PubMed ID: 25110081
[TBL] [Abstract][Full Text] [Related]
10. [Changes in the enzyme activity in the brain structures of August rats under the influence of the delta sleep-inducing peptide against a background of prolonged L-dihydroxyphenylalanine administration].
Sergutina AV; Rakhmanova VI
Morfologiia; 1999; 116(6):9-11. PubMed ID: 10709190
[TBL] [Abstract][Full Text] [Related]
11. Effects of L-DOPA on aggressive behavior and central monoaminergic activity in the lizard Anolis carolinensis, using a new method for drug delivery.
Höglund E; Korzan WJ; Watt MJ; Forster GL; Summers TR; Johannessen HF; Renner KJ; Summers CH
Behav Brain Res; 2005 Jan; 156(1):53-64. PubMed ID: 15474650
[TBL] [Abstract][Full Text] [Related]
12. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
Alachkar A; Brotchie JM; Jones OT
Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
[TBL] [Abstract][Full Text] [Related]
13. [Neurochemical aspects of the cortical-subcortical interrelations after activation of the dopamine system with L-dopa].
Gershteĭn LM; Sergutina AV; Titov SA; Chebotareva TL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(10):68-71. PubMed ID: 1963003
[TBL] [Abstract][Full Text] [Related]
14. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
[TBL] [Abstract][Full Text] [Related]
16. [Effect of L-DOPA on the function of the brain neuromediator systems].
Lovedova EL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(7):19-21. PubMed ID: 3188768
[TBL] [Abstract][Full Text] [Related]
17. Differences in Monoamine Oxidase Activity in the Brain of Wistar and August Rats with High and Low Locomotor Activity: A Cytochemical Study.
Sergutina AV; Rakhmanova VI
Bull Exp Biol Med; 2016 Jun; 161(2):211-4. PubMed ID: 27383157
[TBL] [Abstract][Full Text] [Related]
18. [Autoradiography of protein synthesis as a method of assessment of morphofunctional changes in brain structures].
Khudoerkov RM
Biull Eksp Biol Med; 1991 Sep; 112(9):321-3. PubMed ID: 1747489
[TBL] [Abstract][Full Text] [Related]
19. A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization.
Thomas J; Wang J; Takubo H; Sheng J; de Jesus S; Bankiewicz KS
Exp Neurol; 1994 Apr; 126(2):159-67. PubMed ID: 7925817
[TBL] [Abstract][Full Text] [Related]
20. The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model.
Yin LL; Geng XC; Zhu XZ
Brain Res Bull; 2011 Nov; 86(5-6):367-72. PubMed ID: 21963945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
